Literature DB >> 9476130

Molecular basis of a new type of C1q-deficiency associated with a non-functional low molecular weight (LMW) C1q: parallels and differences to other known genetic C1q-defects.

F Petry1, G Hauptmann, J Goetz, E Grosshans, M Loos.   

Abstract

Analysis of an abnormal C1q molecule of individuals of a Moroccan family by ultracentrifugation in sucrose gradients revealed a low molecular weight C1q (LMW-C1q). We investigated the molecular basis of this defect by sequencing all six exons of the three C1q genes. One point mutation in the codon for Gly at position 15 (GGT) of the B chain was found resulting in an amino acid substitution to Asp (GAT). The exchange not only leads to an interruption of the collagen-like motif Gly-X-Y, but also introduces one negatively charged residue per B chain which results in two additional charges per structural subunit (A-B, C-C, A-B). The mutation which has been identified by DNA-sequencing in the C1q-deficient younger brother of the propositus was confirmed by PCR-EcoRV-RFLP in the sister and the propositus himself. This mutation is very similar to a mutation previously described in another case of functional C1q deficiency where Gly at position 6 of the C chain was substituted by a large positively charged residue (Arg). Again, a LMW-C1q was demonstrated. These point mutations that lead to amino acid substitutions result in the production of a LMW-C1q where the formation of functionally active 11S C1q consisting of three structural subunits appears to be inhibited by the introduction of six additional charges, one per B or C chain, respectively, in the collagenous region of the molecule.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9476130     DOI: 10.1016/s0162-3109(97)00065-9

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  7 in total

Review 1.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

2.  Common silent mutations in all types of hereditary complement C1q deficiencies.

Authors:  Franz Petry; Michael Loos
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

3.  HPV and systemic lupus erythematosus: a mosaic of potential crossreactions.

Authors:  Yahel Segal; Shani Dahan; Michele Calabrò; Darja Kanduc; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 4.  Innate Immunity: A Balance between Disease and Adaption to Stress.

Authors:  Irene Faenza; William L Blalock
Journal:  Biomolecules       Date:  2022-05-23

5.  Evaluation of C1q genomic region in minority racial groups of lupus.

Authors:  B Namjou; C Gray-McGuire; A L Sestak; G S Gilkeson; C O Jacob; J T Merrill; J A James; E K Wakeland; Q-Z Li; C D Langefeld; J Divers; J Ziegler; K L Moser; J A Kelly; K M Kaufman; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

Review 6.  Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.

Authors:  Katherine E Lintner; Yee Ling Wu; Yan Yang; Charles H Spencer; Georges Hauptmann; Lee A Hebert; John P Atkinson; C Yung Yu
Journal:  Front Immunol       Date:  2016-02-15       Impact factor: 7.561

7.  Identification of novel gene and pathway targets for human epilepsy treatment.

Authors:  Ying Jin; Chunzhe Zhao; Lihui Chen; Xiangyu Liu; Shuxiao Pan; Dongsheng Ju; Jing Ma; Jinying Li; Bo Wei
Journal:  Biol Res       Date:  2016-01-07       Impact factor: 5.612

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.